Literature DB >> 7962895

A multicentered clinical study on posterior resin-bonded bridges: the 'Manchester trial'.

M Kellett1, C W Verzijden, G A Smith, N H Creugers.   

Abstract

This study was designed to investigate and identify factors relevant to the success and failure of posterior resin-bonded bridges (PRBBs) related to the patient, technique, operator and bridge design. It was a long-term controlled clinical trial and formed part of a multicentered study on PRBBs. Data are presented 2.5 years from the start of the study. Following a strict protocol for case selection, 54 posterior, resin-bonded, fixed-fixed, three unit bridges were placed in 45 patients. Twenty-four patients with 27 PRBBs attended for 2.5-year recall. Treatment variables were limited to one of two operators and either a conventional tooth preparation or a more extensive modified preparation was performed. The allocation of treatment modalities was performed using a computer program to balance patient variables such as age, gender, location of bridge, restoration of abutment teeth. All bridges were produced in one laboratory, treated to produce a silicate-coating bond and placed using Microfill Pontic C (Kulzer, Wehrheim, Germany). Data relating to the patients, the open spaces, bridge preparation, bridge placement and subsequent annual evaluation were recorded. The survival of PRBBs in the maxilla was 77% and in the mandible 47%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962895     DOI: 10.1016/0300-5712(94)90108-2

Source DB:  PubMed          Journal:  J Dent        ISSN: 0300-5712            Impact factor:   4.379


  2 in total

Review 1.  WITHDRAWN: Interventions for replacing missing teeth: partially absent dentition.

Authors:  Elliot Abt; Alan B Carr; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2019-07-17

2.  Longevity of resin-bonded fixed partial dental prostheses made with metal alloys.

Authors:  Naomi Tanoue
Journal:  Clin Oral Investig       Date:  2015-10-06       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.